Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur A Wilde

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Heart Rhythm|September 30, 2015
Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockadeGareth J Padfield, Leenah AlAhmari, Krystien V V Lieve, et al.
Circulation. Arrhythmia and Electrophysiology|October 14, 2016
Long-Term Outcome of Patients Initially Diagnosed With Idiopathic Ventricular Fibrillation: A Descriptive StudyMarloes Visser, Jeroen F van der Heijden, Jasper J van der Smagt, et al.
Pacing and Clinical Electrophysiology : PACE|April 17, 2015
Quality of Life in Young Adult Patients with a Cardiogenetic Condition Receiving an ICD for Primary Prevention of Sudden Cardiac DeathAgnes J Verkerk, Alexa M Vermeer, Ellen M Smets, et al.
Circulation. Cardiovascular Genetics|April 24, 2015
Enhanced Classification of Brugada Syndrome-Associated and Long-QT Syndrome-Associated Genetic Variants in the SCN5A-Encoded Na(v)1.5 Cardiac Sodium ChannelJamie D Kapplinger, John R Giudicessi, Dan Ye, et al.
Journal of Molecular and Cellular Cardiology|March 23, 2010
The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handlingUwe Kirchhefer, Diana Wehrmeister, Alex V Postma, et al.
Circulation. Arrhythmia and Electrophysiology|January 12, 2017
Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator: An Evaluation of 4 Implantation TechniquesTom F Brouwer, Marc A Miller, Anne-Floor B E Quast, et al.
Journal of the American College of Cardiology|November 5, 2016
Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator TherapyTom F Brouwer, Dilek Yilmaz, Robert Lindeboom, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|August 21, 2008
Phenotypic variability in Caucasian and Japanese patients with matched LQT1 mutationsJudy F Liu, Ilan Goldenberg, Arthur J Moss, et al.
European Heart Journal. Cardiovascular Imaging|January 27, 2012
Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriersWessel P Brouwer, Tjeerd Germans, Maaike C Head, et al.
Heart Rhythm|August 31, 2015
Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1Martin H Ruwald, Xiaorong Xu Parks, Arthur J Moss, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Heart Rhythm|September 30, 2015
Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockadeGareth J Padfield, Leenah AlAhmari, Krystien V V Lieve, et al.
Circulation. Arrhythmia and Electrophysiology|October 14, 2016
Long-Term Outcome of Patients Initially Diagnosed With Idiopathic Ventricular Fibrillation: A Descriptive StudyMarloes Visser, Jeroen F van der Heijden, Jasper J van der Smagt, et al.
Pacing and Clinical Electrophysiology : PACE|April 17, 2015
Quality of Life in Young Adult Patients with a Cardiogenetic Condition Receiving an ICD for Primary Prevention of Sudden Cardiac DeathAgnes J Verkerk, Alexa M Vermeer, Ellen M Smets, et al.
Circulation. Cardiovascular Genetics|April 24, 2015
Enhanced Classification of Brugada Syndrome-Associated and Long-QT Syndrome-Associated Genetic Variants in the SCN5A-Encoded Na(v)1.5 Cardiac Sodium ChannelJamie D Kapplinger, John R Giudicessi, Dan Ye, et al.
Journal of Molecular and Cellular Cardiology|March 23, 2010
The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handlingUwe Kirchhefer, Diana Wehrmeister, Alex V Postma, et al.
Circulation. Arrhythmia and Electrophysiology|January 12, 2017
Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator: An Evaluation of 4 Implantation TechniquesTom F Brouwer, Marc A Miller, Anne-Floor B E Quast, et al.
Journal of the American College of Cardiology|November 5, 2016
Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator TherapyTom F Brouwer, Dilek Yilmaz, Robert Lindeboom, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|August 21, 2008
Phenotypic variability in Caucasian and Japanese patients with matched LQT1 mutationsJudy F Liu, Ilan Goldenberg, Arthur J Moss, et al.
European Heart Journal. Cardiovascular Imaging|January 27, 2012
Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriersWessel P Brouwer, Tjeerd Germans, Maaike C Head, et al.
Heart Rhythm|August 31, 2015
Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1Martin H Ruwald, Xiaorong Xu Parks, Arthur J Moss, et al.
Pageof 8